Lipid nanoparticle compositions and methods of formulating the same Grant US-11524023-B2 United States of America 13 Dec 2022
IMMUNOGENIC COMPOSITION AGAINST INFLUENZA Application WO-2022234417-A1 World Intellectual Property Organisation (WIPO) 10 Nov 2022
THE POLARITY AND SPECIFICITY OF SARS-COV2 -SPECIFIC T LYMPHOCYTE RESPONSES AS A BIOMARKER… Application WO-2022229461-A1 World Intellectual Property Organisation (WIPO) 03 Nov 2022
INDUCTION OF IMMUNITY TO SARS-COV-2 IN CHILDREN Application WO-2022197209-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2022
ANTIBODIES CONJUGATED OR FUSED TO THE RECEPTOR-BINDING DOMAIN OF THE SARS-COV-2 SPIKE… Application WO-2022101302-A1 World Intellectual Property Organisation (WIPO) 19 May 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086364-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Application WO-2022086365-A1 World Intellectual Property Organisation (WIPO) 28 Apr 2022
VIRAL VACCINE VECTOR FOR IMMUNIZATION AGAINST A BETACORONAVIRUS Application WO-2021233989-A1 World Intellectual Property Organisation (WIPO) 25 Nov 2021
NUCLEIC ACID VACCINES FOR CORONAVIRUS Application WO-2021204179-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021
USE OF ANTI-IL-6 ANTIBODY, E.G., CLAZAKIZUMAB FOR TREATMENT/PREVENTION OF ARDS ASSOCIATED… Application WO-2021188727-A1 World Intellectual Property Organisation (WIPO) 23 Sep 2021